59th Annual Meeting of the Japanese Society of Neurology

Presentation information

Print

Luncheon Seminar

[LS-01] Medical Division, Novartis Pharma K.K.

It is time to think about the benefit-risk balance of fingolimod from the perspectives in case reports

Wed. May 23, 2018 12:05 PM - 1:05 PM Room 5 (Sapporo Geibunkan / Seiryu （3F）)

Chair: Takashi Yamamura(Director and Chief of the Neuroimmunology Section, Director of Multiple Sclerosis Center, the Department of Immunology, National Institute of Neuroscience,
National Center of Neurology and Psychiatry)

[LS-01-2] 今改めて考えるフィンゴリモドのリスクベネフィットバランス ~症例からの考察~

○Masaaki Niino (Director, Department of Clinical Research Hokkaido Medical Center)